Copan Diagnostics

Murrieta, California, USA  All United States companies → — Founded 1994
Medical Device / Hardware Point-of-Care Diagnostics
Infectious Disease Laboratory Medicine
Lab & Diagnostics Pathology AI
Grant
Website Claim this company

Products

PhenoMATRIX
Copan Diagnostics
Lab & Diagnostics
PhenoMATRIX® is an AI-driven image interpretation suite integrated into routine clinical microbiology, combining AI, LIS data, and lab-specific rules to analyze colony features in digital images and automatically interpret bacterial culture plates.
Contact for pricing

See all 1 product →

About Copan Diagnostics

Copan Diagnostics is a global leader in pre-analytical solutions for microbiology, dedicated to advancing healthcare through innovative sample collection, transport, and laboratory automation. The company’s offerings are designed to enhance laboratory efficiency and accuracy, ultimately contributing to improved patient care. Copan has pioneered breakthrough technologies such as FLOQSwabs®, ESwab®, and UTM® Universal Transport Medium™, which have revolutionized specimen collection by improving pathogen recovery and optimizing the diagnostic process.

Beyond consumables, Copan Diagnostics is at the forefront of laboratory automation and artificial intelligence (AI) in microbiology. Their solutions, including the WASPLab® Full Laboratory Automation system and PhenoMATRIX® AI-powered image assessment software, streamline workflows from specimen processing to digital imaging and AI interpretation. PhenoMATRIX®, for instance, is FDA 510(k) cleared and uses AI to automatically sort culture plate images, helping laboratories enhance efficiency and maintain expert control. Copan’s commitment extends to developing comprehensive solutions that integrate automation and AI to address the challenges faced by clinical microbiology laboratories, molecular, pharmaceutical, and food safety laboratories.

Focus Areas

Sample Collection & Transport Full Laboratory Automation Digital Microbiology Artificial Intelligence Pre-analytics Molecular Diagnostics

Business Intelligence

TechnologyCloud-native (for PhenoMATRIX® integration with WASPLab®), robotics, advanced imaging, AI algorithms

What Physicians Need to Know

Microbiology Automation
Copan Diagnostics specializes in full laboratory automation for microbiology, encompassing specimen sorting, processing, smart incubation, specialized imaging, and AI interpretation. Their WASPu00ae (Walk-Away Specimen Processor) system automates tasks like planting, streaking, Gram slide preparation, broth inoculation, and disk application.
AI-Powered Image Analysis
Copan's PhenoMATRIXu00ae AI software, which is FDA 510(k)-cleared, uses artificial intelligence and laboratory-defined rules to automatically sort digital images of culture media plates. It assists technologists in assessing and defining results by detecting microbial growth, estimating colony counts, and differentiating isolates based on phenotypic characteristics.
Pre-analytical Solutions
Copan offers comprehensive pre-analytical solutions, including innovative sample collection and transport systems like FLOQSwabsu00ae, ESwabu2122, and UTMu00ae Universal Transport Mediumu2122. They also provide systems for urine (UriSpongeu00ae), fecal (FecalSwabu00ae), and sputum (SnotBusteru2122) specimen management, which are crucial for maintaining sample integrity and optimizing downstream testing.
Full Laboratory Automation (FLA)
The WASPLabu00ae system serves as the central hub for Copan's Full Laboratory Automation, integrating specimen processing, smart incubation, digital microbiology, and AI for plate reading. This modular and scalable system aims to maximize clinical microbiology productivity and enhance quality, safety, and traceability.
Enhanced Traceability
Copan's automation systems, such as WASPu00ae, incorporate barcode-driven technology with 360u00b0 scanning to accurately read barcodes on specimen containers from any angle, ensuring enhanced traceability and consistent matching of patient specimen barcodes with labels on plates, slides, and inoculation tubes.
Physician Tip

For physicians, Copan Diagnostics' AI tools and automation systems in microbiology can lead to faster and more accurate diagnostic results, ultimately improving patient care. The automation of pre-analytical steps reduces human error and standardizes processes, leading to more consistent and reliable lab results. Specifically, the PhenoMATRIXu00ae AI can help accelerate the identification of pathogens like MRSA, VRE, and Group B Streptococcus, allowing for quicker treatment decisions. The comprehensive automation also allows laboratory professionals to focus on more complex tasks, leading to more efficient use of resources and potentially broader screenings.

Copan's systems are designed to be open platforms, offering compatibility with various culture plate brands for flexibility and cost savings. Their AI software, PhenoMATRIXu00ae, integrates with Laboratory Information Systems (LIS) to combine patient information with image analysis for automated sorting of culture plates. The WASPLabu00ae system is also modular and scalable, allowing for customization and integration into existing laboratory workflows.

Products by Copan Diagnostics

1 product in the directory

PhenoMATRIX
Copan Diagnostics
Lab & Diagnostics
PhenoMATRIX® is an AI-driven image interpretation suite integrated into routine clinical microbiology, combining AI, LIS data, and lab-specific rules to analyze colony features in digital images and automatically interpret bacterial culture plates.
Contact for pricing

What the Web Says

Copan Diagnostics receives mixed reviews, with product feedback generally positive regarding their innovative sample collection and automation systems, while employer reviews highlight significant concerns about management, pay, and work-life balance. Their products like WASPu00ae, ESwabu00ae, and FecalSwabu00ae are praised for improving lab efficiency and diagnostic capabilities. However, employee satisfaction appears to be low in several key areas.

Overall: Mixed

Strengths

  • Innovative and high-quality sample collection and transport systems (e.g., ESwabu00ae, FecalSwabu00ae).
  • Laboratory automation systems (WASPu00ae) save time and improve efficiency in microbiology labs.
  • AI-powered software (PhenoMATRIXu00ae) streamlines plate review and improves efficiency.
  • Products are FDA-cleared and compatible with various molecular testing platforms.
  • Good after-sales service and engineering support for their automation products.
  • Supportive environment and time/location flexibility noted by some employees.

Limitations

  • Poor management is a recurring issue in employer reviews.
  • Low ratings for pay and benefits.
  • Concerns about job security and advancement opportunities.
  • Work-life balance is rated poorly by many employees.
  • Toxic work environment with rumors and gossip reported.
  • Consumables for automation systems can be expensive.

Based on reviews from: Indeed.com, Select Science, Copan Diagnostics Official Website

Last updated: 2026-10-06

Videos

News, demos, and interviews about Copan Diagnostics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Copan Diagnostics →

View all on YouTube

Press & Coverage

Copan Diagnostics
PhenoMATRIXu00ae Receives FDA 510(k) Clearance: Advancing Digital Microbiology with Confidence
Copan Diagnostics announced that its AI-powered image assessment software, PhenoMATRIXu00ae, received FDA 510(k) clearance as a Class II medical device, a significant step for digital microbiology. This clearance allows laboratories to use the system for automatic sorting of digital images of culture media plates, streamlining review and improving efficiency.
2026-02
Copan Diagnostics
Copan Expands U.S. Manufacturing Footprint with Multimillion-Dollar Investment
Copan Diagnostics is investing over $7 million to expand its US manufacturing presence in California and Puerto Rico, aiming to strengthen production of respiratory and urine specimen collection kits and localize critical supply chains. This initiative includes facility expansions, new manufacturing processes, and increased US sourcing of components and reagents.
2025-09
Copan Diagnostics
Copan Launches UriVerseu2122: Fully Automated Solution for Urine Specimen Aliquoting
Copan launched UriVerseu2122, a fully automated system for pre-analytical handling of urine specimens, automating critical steps like de-capping, barcode labeling, aliquoting, and re-capping. This solution aims to help laboratories meet rising urine testing demands, reduce manual labor, and minimize errors.
2025-08
Medical Product Outsourcing
FDA Clears Copan Diagnostics' Urine Collection Device
Copan Diagnostics' UriSpongeu00ae, a urine collection and transport device with advanced preservatives, received U.S. FDA clearance. This device offers a user-friendly, reliable, and cost-effective way to improve urine specimen collection, preservation, and transport.
2025-01
Copan Diagnostics
Study Presented at CACMID 2024 Highlights Copan's UniVerseu00ae as a Game-Changer in Clinical Molecular Specimen Preparation
A study presented at CACMID 2024 showcased Copan's UniVerseu00ae automated instrument for pre-analytical processing of clinical samples, demonstrating a 50% reduction in hands-on time and enhancing workflow. This innovation aims to improve efficiency and accuracy in clinical testing.
2024-07
Copan Diagnostics
Study Validates Effectiveness of Copan FecalSwabu00ae for Enteric Pathogen Detection on the BD MAXu2122 System
A recent study published in the Journal of Clinical Microbiology supports the use of Copan's FecalSwabu00ae system with the BD MAXu2122 platform for enteric pathogen detection. The study found FecalSwabu00ae matched the sensitivity of traditional bulk stool samples and showed enhanced detection in samples with low pathogen concentrations.
2024-08
Copan Diagnostics
Copan Diagnostics Announces Leadership Change
COPAN Group announced the departure of Norman Sharples, CEO of Copan Diagnostics, and the appointment of Fabrizio Mazzocchi as the new CEO, effective January 9th, 2023. Mazzocchi brings 30 years of global experience in the healthcare sector to the position.
2023-02
Apple Newsroom
Apple awards $10 million from Advanced Manufacturing Fund to COPAN Diagnostics
Apple awarded $10 million from its Advanced Manufacturing Fund to COPAN Diagnostics to rapidly accelerate the supply of sample collection kits for hospitals across the United States, expanding production to over one million kits per week. Apple also supported COPAN's expansion to a new, larger facility in Southern California.
2020-05

Frequently Asked Questions

Copan Diagnostics' flagship AI product is PhenoMATRIXu00ae, an FDA 510(k)-cleared software suite that integrates with their WASPLabu00ae automated system. PhenoMATRIXu00ae uses AI to analyze digital images of culture plates, automatically sorting them based on growth, morphology, and other lab-defined rules to streamline microbiology workflows and assist technologists with final assessment.
Copan Diagnostics is committed to regulatory compliance. Their PhenoMATRIXu00ae software is FDA 510(k)-cleared as a Class II Device for its intended use in the United States. They also adhere to EU IVDR and MDR regulations, ensuring product conformity for CE-marked devices. However, some PhenoMATRIXu00ae functionalities or configurations may be labeled Research Use Only (RUO) in the US, and availability and regulatory status can vary by country.
Specific pricing for Copan Diagnostics' AI solutions like PhenoMATRIXu00ae is not publicly disclosed and typically requires direct contact with a local representative or distributor. Factors that may influence pricing and implementation time include the complexity of the chosen AI software package (e.g., Essentials, Elite with TAG, Select), additional protocols, and integration with existing laboratory systems.
Copan Diagnostics emphasizes comprehensive support, including change management, workflow analysis, verification guidance, and training for their automation and AI solutions. They also ensure that spare parts and technical support are provided by Copan or its authorized distributors to guarantee reliability and correct functioning of their instruments.
Yes, Copan Diagnostics actively engages in collaborations. They have worked with institutions like ARUP Laboratories for algorithm training and evaluation of their PhenoMATRIXu00ae AI software. Historically, they've also partnered with companies like Apple to streamline manufacturing and supply chains for critical healthcare products.
Copan Diagnostics, part of the privately held Copan Group, has been a global leader in pre-analytical innovations since 1979, demonstrating long-term stability. They are committed to continuous innovation in laboratory automation and AI, with a vision to enhance efficiency, quality, and patient care in clinical microbiology. Their investments include expanding U.S. manufacturing and developing future AI-driven solutions like MicroHubu00ae.

Related Companies

Pe
Perimeter Medical Imaging AI
Toronto, Canada and Dallas, Texas, USA

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS
Rolle, Switzerland and Boston, Massachusetts, United States

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
DeepBio
Seoul, South Korea

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
AIRA Matrix
Thane, Maharashtra, India

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]
AI-LabTest

AI-LabTest is a secure, AI-powered digital health platform designed to help individuals understand their medical lab reports. The platform analyzes uploaded bloodwork or diagnostic results (in PDF, JPG, or TXT formats) and translates complex medical data into clear, personalized summaries. These summaries highlight key findings, potential implications, and practical next steps in patient-friendly language. The […]
Google DeepMind
London, United Kingdom, with research centers in the United States, Canada, France, Germany, and Switzerland. The London headquarters is located at Platform 37, Kings Cross Central.

Google DeepMind is a British-American artificial intelligence (AI) research laboratory and a subsidiary of Alphabet Inc.. Formed in April 2023 through the merger of DeepMind and Google AI’s Google Brain division, the company focuses on advancing artificial general intelligence (AGI) and developing AI systems for widespread public benefit and scientific discovery. Their work involves an […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.